vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v12i5.807vsp-290Research ArticleВ ПОМОЩЬ ВРАЧУA DOCTOR’S AIDДИНАМИКА СОДЕРЖАНИЯ СЫВОРОТОЧНЫХ МАРКЕРОВ АПОПТОЗА ДЛЯ ОЦЕНКИ ПРОГНОЗА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У ДЕТЕЙDYNAMICS OF CONCENTRATION OF APOPTOSIS SERUM MARKERS IN ASSESSMENT OF PROGNOSIS OF CHRONIC KIDNEY DISEASE IN CHILDRENКомароваО. В.KomarovaO. V.
Komarova Olga Viktorovna, Candidate of Medical Sciences, Senior Researcher of the Department of Nephrology
komarova@nczd.ruКучеренкоА. Г.KucherenkoA. G.komarova@nczd.ruСмирновИ. Е.SmirnovI. E.komarova@nczd.ruЦыгинА. Н.TsyginA. N.komarova@nczd.ruНаучный центр здоровья детей РАМН, МоскваРоссияScientific Centre of Children Health of RAMS, MoscowRussian Federation201319092013125Вопросы современной педиатрии104107Copyright © Комарова О.В., Кучеренко А.Г., Смирнов И.Е., Цыгин А.Н., 20132013Комарова О.В., Кучеренко А.Г., Смирнов И.Е., Цыгин А.Н.Komarova O.V., Kucherenko A.G., Smirnov I.E., Tsygin A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/290детихроническая болезнь почекапоптозFas-опосредованныйchildrenchronic kidney diseaseapoptosisFas-inducedReferencesNational Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39 (2 Suppl. 1): 1–266.National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39 (2 Suppl. 1): 1–266.Smirnov A. V., Dobronravov V. A., Kayukov I. G. et al. Khroniches kaya Bolezn' Pochek: Dal'neyshee Razvitie Kontseptsii i Klassifikatsii [Chronic Kidney Disease: Further Development of the Concept and Classification]. Nefrologiya [Nephrology]. 2007; 11 (4): 7–17.Smirnov A. V., Dobronravov V. A., Kayukov I. G. et al. Khroniches kaya Bolezn' Pochek: Dal'neyshee Razvitie Kontseptsii i Klassifikatsii [Chronic Kidney Disease: Further Development of the Concept and Classification]. Nefrologiya [Nephrology]. 2007; 11 (4): 7–17.Fogo A. B. Mechanisms of progression of chronic kidney disease. Pediatr. Nephrol. 2007; 2: 2011–2022.Fogo A. B. Mechanisms of progression of chronic kidney disease. Pediatr. Nephrol. 2007; 2: 2011–2022.Bohle A., Muller G. A., Wehrmann M. et al. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Am. J. Kidney Dis. 1996; 49 (Suppl.): 2–9.Bohle A., Muller G. A., Wehrmann M. et al. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Am. J. Kidney Dis. 1996; 49 (Suppl.): 2–9.Komarova O. V., Kucherenko A. G., Smirnov I. E., Tsygin A. N. Rol' Narusheniy Protsessov Apoptoza v Progressirovanii Khronicheskoy Bolezni Pochek u Detey [Role of Apoptosis Disorders in the Progression of Chronic Kidney Disease in Children]. Nefrologiya i dializ [Nephrology and Dialysis]. 2013; 15: 135–139.Komarova O. V., Kucherenko A. G., Smirnov I. E., Tsygin A. N. Rol' Narusheniy Protsessov Apoptoza v Progressirovanii Khronicheskoy Bolezni Pochek u Detey [Role of Apoptosis Disorders in the Progression of Chronic Kidney Disease in Children]. Nefrologiya i dializ [Nephrology and Dialysis]. 2013; 15: 135–139.Shirokova A. V. Apoptoz. Signal'nye Puti i Izmenenie Ionnogo i Vodnogo Balansa Kletki [Apoptosis. Signaling Pathways and Changes in Ion and Water Balance of the Cell]. Tsitologiya [Cytology]. 2007; 49 (5): 385–394.Shirokova A. V. Apoptoz. Signal'nye Puti i Izmenenie Ionnogo i Vodnogo Balansa Kletki [Apoptosis. Signaling Pathways and Changes in Ion and Water Balance of the Cell]. Tsitologiya [Cytology]. 2007; 49 (5): 385–394.Jaber B. L., Perianayagam M.C., Balakrishnan V. S., King A. J. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. J. Leuk. Biol. 2001; 69 (6): 1006–1012.Jaber B. L., Perianayagam M.C., Balakrishnan V. S., King A. J. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. J. Leuk. Biol. 2001; 69 (6): 1006–1012.Green D. R., Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004; 305 (5684): 626–629.Green D. R., Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004; 305 (5684): 626–629.Dounousi E., Koliousi E., Papagianni A. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease. Am. J. Nephrol. 2012; 36: 531–536.Dounousi E., Koliousi E., Papagianni A. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease. Am. J. Nephrol. 2012; 36: 531–536.Hughes J., Savill J. S. Apoptosis in glomerulonephritis. Curr. Opin. Nephrol. Hypertens. 2005; 14 (4): 389–395.Hughes J., Savill J. S. Apoptosis in glomerulonephritis. Curr. Opin. Nephrol. Hypertens. 2005; 14 (4): 389–395.Tao Y., Kim J., Stanley M. et al. Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int. 2005; 67: 909–919.Tao Y., Kim J., Stanley M. et al. Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int. 2005; 67: 909–919.Moiseev S. V., Arutyunov G. P., Fomin V. V. Ingibitory APF i Nefroprotektsiya pri Khronicheskikh Zabolevaniyakh Pochek s Proteinuriey [ACE Inhibitors and Nephroprotection at Chronic Kidney Disease with Proteinuria]. Klinicheskaya Nefrologiya [Clinical Nephrology]. 2009; 2: 31–36.Moiseev S. V., Arutyunov G. P., Fomin V. V. Ingibitory APF i Nefroprotektsiya pri Khronicheskikh Zabolevaniyakh Pochek s Proteinuriey [ACE Inhibitors and Nephroprotection at Chronic Kidney Disease with Proteinuria]. Klinicheskaya Nefrologiya [Clinical Nephrology]. 2009; 2: 31–36.Bakris G. L. Slowing nephropathy progression: focus on proteinuria reduction. Clin. J. Am. Soc. Nephrol. 2008; 3: 3–10.Bakris G. L. Slowing nephropathy progression: focus on proteinuria reduction. Clin. J. Am. Soc. Nephrol. 2008; 3: 3–10.Metcalfe W. How does early chronic kidney disease progress. Nephrol. Dial. Transplant. 2007; 22 (Suppl. 9): 26–30.Metcalfe W. How does early chronic kidney disease progress. Nephrol. Dial. Transplant. 2007; 22 (Suppl. 9): 26–30.
The authors declare that there are no conflicts of interest present.